bio2018-mybio-sessionicon-companypres

Avillion LLP Company Presentation

5:00 PM–5:15 PM Jun 3, 2019

Theater 4

Description

Accelerating global drug development through successful partnering for patient benefit. Our objective is to enable our partners to continue to develop their most important drug candidates without increasing the burden on their P&L or cash reserves.

Session ID: 531669

Tags